US OptionsDetailed Quotes

TELA241220C5000

Watchlist
  • 0.05
  • 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

Comments

    $TELA Bio (TELA.US)$
    TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
    TELA Bio has announced the pricing of a public offering comprising 12,000,000 shares of common stock at $2.25 per share and pre-funded warrants for 5,800,000 shares at $2.2499 per warrant. The offering is expected to generate $40 million in gross proceeds before expenses. The company has granted underwriters a 30-day option to purchase up to 2,670,000 additional shares. The offering, exp...
    $TELA Bio (TELA.US)$
    NEWS
    TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
    TELA Bio, Inc. announces the U.S. commercial launch of OviTex IHR, a reinforced tissue matrix for inguinal hernia repair. The product offers trocar-compatibility for laparoscopic and robotic procedures, with three configurations available. OviTex has a strong clinical track record with low recurrence rates and high pati...
    $TELA Bio (TELA.US)$
    Beat revenue estimates and near miss on GAAP.
    FDA approved surgical device
    Buy this asap
    Despite TELA Bio's high revenue growth, its P/S ratio barely aligns with industry median, indicating public skepticism about future growth. Its current stock price could be attractive, yet it shows two risk signs.
Read more